BR0207271A - Composição farmacêutica - Google Patents
Composição farmacêuticaInfo
- Publication number
- BR0207271A BR0207271A BR0207271-8A BR0207271A BR0207271A BR 0207271 A BR0207271 A BR 0207271A BR 0207271 A BR0207271 A BR 0207271A BR 0207271 A BR0207271 A BR 0207271A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- thieno
- benzo
- chloro
- cycloexanecarboxylic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
"COMPOSIçãO FARMACêUTICA". A invenção refere-se a uma composição farmacêutica para administração oral de ácido 4-[4-(3-cloro-4-metoxibenzilamino)benzo[4,5]tieno-[2,3-dlpirimidin-2-il] -cicloexanocarboxflico e/ou ácido 4-[4-(3-cloro-4-hidroxibenzilamino)benzo[4,5]tieno[2,3-d]pirimidin-2-il] -cicloexanocarboxílico ou sais farmaceuticamente aceitáveis dos mesmos, a um processo para a preparação da composição farmacêutica e ao uso da mesma.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10107261A DE10107261B4 (de) | 2001-02-16 | 2001-02-16 | Pharmazeutische Zusammensetzung |
| PCT/EP2002/000609 WO2002072100A2 (en) | 2001-02-16 | 2002-01-23 | Pharmaceutical composition containing pde v inhibitors and surfactants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0207271A true BR0207271A (pt) | 2004-03-23 |
Family
ID=7674278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0207271-8A BR0207271A (pt) | 2001-02-16 | 2002-01-23 | Composição farmacêutica |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20040082600A1 (pt) |
| EP (1) | EP1385521A2 (pt) |
| JP (1) | JP2004519489A (pt) |
| KR (1) | KR20030074822A (pt) |
| CN (1) | CN1649592A (pt) |
| AR (1) | AR032695A1 (pt) |
| BR (1) | BR0207271A (pt) |
| CA (1) | CA2438401A1 (pt) |
| CZ (1) | CZ20032423A3 (pt) |
| DE (1) | DE10107261B4 (pt) |
| EC (1) | ECSP034769A (pt) |
| EE (1) | EE200300378A (pt) |
| HU (1) | HUP0303141A3 (pt) |
| IL (1) | IL157411A0 (pt) |
| MX (1) | MXPA03007318A (pt) |
| PE (1) | PE20021039A1 (pt) |
| PL (1) | PL364467A1 (pt) |
| RU (1) | RU2003127393A (pt) |
| SK (1) | SK11352003A3 (pt) |
| WO (1) | WO2002072100A2 (pt) |
| ZA (1) | ZA200307216B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101065115A (zh) * | 2004-11-24 | 2007-10-31 | 默克公司 | 取代酰胺的液体和半固体口服药物制剂 |
| US8703786B2 (en) * | 2011-12-07 | 2014-04-22 | Texas Southern University | Etravirine formulations and uses thereof |
| JP6943384B2 (ja) * | 2017-03-01 | 2021-09-29 | ヱスビー食品株式会社 | 食品の食感劣化防止用ソフトカプセル、並びに、該食感劣化防止用ソフトカプセル及び食用油を含有する食品 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1766592A (en) * | 1991-06-03 | 1993-01-08 | Merck Sharp & Dohme Limited | Pharmaceutical formulations of a benzodiazepine |
| DE19819023A1 (de) * | 1998-04-29 | 1999-11-04 | Merck Patent Gmbh | Thienopyrimidine |
| DE19928146A1 (de) * | 1999-06-19 | 2000-12-21 | Merck Patent Gmbh | Thienopyrimidine |
| US20030153585A1 (en) * | 2000-01-13 | 2003-08-14 | Sven-Alexander Schreder | Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary |
| DE10001021A1 (de) * | 2000-01-13 | 2001-07-19 | Merck Patent Gmbh | Pharmazeutische Zubereitung |
-
2001
- 2001-02-16 DE DE10107261A patent/DE10107261B4/de not_active Expired - Fee Related
-
2002
- 2002-01-23 EP EP02701263A patent/EP1385521A2/en not_active Withdrawn
- 2002-01-23 EE EEP200300378A patent/EE200300378A/xx unknown
- 2002-01-23 SK SK1135-2003A patent/SK11352003A3/sk not_active Application Discontinuation
- 2002-01-23 WO PCT/EP2002/000609 patent/WO2002072100A2/en not_active Application Discontinuation
- 2002-01-23 CZ CZ20032423A patent/CZ20032423A3/cs unknown
- 2002-01-23 KR KR10-2003-7010607A patent/KR20030074822A/ko not_active Application Discontinuation
- 2002-01-23 BR BR0207271-8A patent/BR0207271A/pt not_active IP Right Cessation
- 2002-01-23 US US10/467,788 patent/US20040082600A1/en not_active Abandoned
- 2002-01-23 CA CA002438401A patent/CA2438401A1/en not_active Abandoned
- 2002-01-23 PL PL02364467A patent/PL364467A1/xx unknown
- 2002-01-23 IL IL15741102A patent/IL157411A0/xx unknown
- 2002-01-23 HU HU0303141A patent/HUP0303141A3/hu unknown
- 2002-01-23 CN CNA028050061A patent/CN1649592A/zh active Pending
- 2002-01-23 RU RU2003127393/15A patent/RU2003127393A/ru not_active Application Discontinuation
- 2002-01-23 MX MXPA03007318A patent/MXPA03007318A/es unknown
- 2002-01-23 JP JP2002571059A patent/JP2004519489A/ja not_active Withdrawn
- 2002-02-15 AR ARP020100516A patent/AR032695A1/es not_active Application Discontinuation
- 2002-02-15 PE PE2002000135A patent/PE20021039A1/es not_active Application Discontinuation
-
2003
- 2003-09-15 ZA ZA200307216A patent/ZA200307216B/en unknown
- 2003-09-15 EC EC2003004769A patent/ECSP034769A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004519489A (ja) | 2004-07-02 |
| WO2002072100A3 (en) | 2003-11-06 |
| ECSP034769A (es) | 2003-12-24 |
| PE20021039A1 (es) | 2002-11-14 |
| PL364467A1 (en) | 2004-12-13 |
| EP1385521A2 (en) | 2004-02-04 |
| KR20030074822A (ko) | 2003-09-19 |
| CA2438401A1 (en) | 2002-09-19 |
| SK11352003A3 (sk) | 2003-12-02 |
| WO2002072100A2 (en) | 2002-09-19 |
| DE10107261A1 (de) | 2002-09-12 |
| DE10107261B4 (de) | 2005-03-10 |
| ZA200307216B (en) | 2005-01-13 |
| RU2003127393A (ru) | 2005-01-20 |
| IL157411A0 (en) | 2004-03-28 |
| CZ20032423A3 (en) | 2004-07-14 |
| MXPA03007318A (es) | 2003-12-04 |
| EE200300378A (et) | 2003-10-15 |
| CN1649592A (zh) | 2005-08-03 |
| US20040082600A1 (en) | 2004-04-29 |
| HUP0303141A2 (hu) | 2003-12-29 |
| HUP0303141A3 (en) | 2006-05-29 |
| AR032695A1 (es) | 2003-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002243387A1 (en) | Pharmaceutical dosage form for oral administration of low molecular weight heparin | |
| BR0114610A (pt) | Composto, uso do mesmo, e, composição farmacêutica | |
| BR0003365A (pt) | Composições farmacêuticas | |
| AUPR213700A0 (en) | Antiviral agents | |
| BRPI0108435B8 (pt) | formulação e uso de entecavir de baixa dose | |
| BR0213522B8 (pt) | compostos derivados de hidroxipirimidinona, composição farmacêutica, e, uso de um composto | |
| BR0215312A (pt) | Uso de um composto, método para inibir a aurora quinase em um animal de sangue quente, composto, composição farmacêutica, e, processo para a preparação de um composto | |
| ME00520B (me) | Levodop/karbidop/entakapon farmaceutski preparat | |
| YU58103A (sh) | Farmaceutski preparati, dozirane forme i postupci za oralnu primenu epotilona | |
| HUP0302319A3 (en) | Pharmaceutical composition for oral administration of active ingredient | |
| WO2002088100A3 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
| BR0214243A (pt) | Derivado de sulfonamida processo para a preparação de um derivado de sulfonamida e seus sais fisiologicamente aceitáveis, composição farmacêutica e uso de um derivado de sulfonamida | |
| MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
| BR9914156A (pt) | Formulação de 2-metil-tieno-benzodiazepina | |
| BR9916887A (pt) | Uso de derivados de pirimidina | |
| SE9902935D0 (sv) | Pharmaceutical compositions | |
| BR0207271A (pt) | Composição farmacêutica | |
| BR0111055A (pt) | Formulação farmacêutica, e, processo para a preparação e uso da mesma | |
| SE9902937D0 (sv) | Pharmaceutical compositions | |
| HUP0402092A2 (hu) | 2-[5-(4-Fluorfenil)-3-piridilmetilaminometil]-kromán vegyületek és fiziológiásan elfogadható sói alkalmazása gyógyszerkészítmények előállítására | |
| WO2001068063A3 (en) | Novel use of (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts | |
| YU87501A (sh) | Farmaceutski kompleksi | |
| BR0014233A (pt) | Conjugados de 4-benzilaminoquinolina com ácido galênico e seus heteroanálogos, processos para a sua preparação, medicamentos contendo estes compostos e sua aplicação | |
| EP1411956B8 (en) | Use of oversulfated polysaccharides as inhibitors of hiv | |
| SE9902938D0 (sv) | Pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5O, 6O E 7O ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2029 DE 24/11/2009. |